Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 21 - Drugs for disorders of the muscular or neuromuscular system
Patents for A61P 21 - Drugs for disorders of the muscular or neuromuscular system (23,287)
05/2010
05/25/2010CA2439295C Carbamate compounds for use in preventing or treating neurodegenerative disorders
05/25/2010CA2403423C Tri-aryl-substituted-ethane pde4 inhibitors
05/20/2010WO2010039823A8 Compositions and methods for tissue repair with extracellular matrices
05/20/2010WO2009121623A3 Compounds for treating muscular dystrophy
05/20/2010WO2009098577A3 Non-immunosuppressive cyclosporin for the treatment of muscular dystrophy
05/20/2010US20100125099 Therapeutic intervention in a genetic disease in an individual by modifying expression of an aberrantly or abnormally expressed gene
05/20/2010US20100125079 Biphenyl compounds useful as muscarinic receptor antagonists
05/20/2010DE102008057867A1 Fettemulsion zur künstlichen Ernährung von schwerkranken Intensivpatienten Fat emulsion for parenteral nutrition of critically ill ICU patients
05/19/2010EP2186520A1 Therapeutic agent for fibromyalgia syndrome and therapeutic agent for pain due to vascular smooth muscle spasm
05/19/2010EP2186407A1 Embryonic-like stem cells derived from post-partum mammalian placenta and uses and methods of treatment using said cells
05/19/2010EP1463487B1 Liposomal delivery of vitamin e based compounds
05/19/2010EP1292671B9 Method for obtaining characterised muscle-derived cell populations and uses
05/19/2010CN101708261A Chinese medicinal patch for treating stiff neck
05/19/2010CN101066319B Chinese medicine composition for treating flaccidity syndrome
05/19/2010CN101028472B Oral Chinese medicinal composition for treating lumbocostal overstrain
05/18/2010US7718702 Cannabinoid receptor ligands
05/18/2010US7718606 Methods for treating muscle diseases and disorders
05/18/2010CA2472475C 17-hydroxy-4-aza-androstan-3-ones as androgen receptor modulators
05/18/2010CA2465247C Benzimidazoles and analogues and their use as protein kinases inhibitors
05/18/2010CA2304204C Quinoline-containing .alpha.-ketoamide cysteine and serine protease inhibitors
05/18/2010CA2284041C Indolecarboxamides, pharmaceutical compositions and methods of inhibiting calpain
05/18/2010CA2121698C Synthesis of human procollagens and collagens in recombinant dna systems
05/14/2010WO2010053182A1 Kynurenine production inhibitor
05/14/2010WO2010052563A2 Glycoproteins having lipid mobilizing properties and therapeutic uses thereof
05/14/2010WO2010017135A3 Novel forms of eperisone
05/14/2010WO2010014798A3 Pyrimidotriazinediones and pyrimidopyrimidinediones and methods of using the same
05/14/2010WO2010009312A3 Compositions comprising mg29 nucleic acids, polypeptides and associated methods of use
05/14/2010WO2010005565A3 Method of treating glycogen storage disease
05/14/2010CA2743026A1 Glycoproteins having lipid mobilizing properties and therapeutic uses thereof
05/13/2010US20100120015 Method of collecting placental stem cells
05/12/2010EP2184296A1 Fibroblast growth factor (fgf23) and methods for use
05/12/2010EP2183027A1 Organic compounds
05/12/2010EP1173169B1 Aryl substituted pyrazoles, imidazoles, oxazoles, thiazoles and pyrroles, and the use thereof
05/12/2010CN1939895B Compound, composition and method for preventing from neurodegeneration in injury of central nervous system
05/12/2010CN1617715B Treating muscle wasting with selective androgen receptor modulators
05/11/2010US7714003 Imidazo[2,1-b ]-1,3,4-thiadiazole sulfonamides
05/11/2010US7713984 Pharmaceutical uses
05/11/2010US7713725 Using expression vector containing inducible regulatory sequences associated with cellulase transcription to control expression of heterologous nucleotide sequences in cells; identifying glucanase activators
05/11/2010CA2412968C Substituted pyridines as selective cyclooxygenase-2 inhibitors
05/11/2010CA2395254C Branched polyalkylene glycols
05/06/2010WO2010050802A2 Methods and means for efficient skipping of at least one of the following exons of the human duchenne muscular dystrophy gene: 43, 46, 50- 53.
05/06/2010WO2010050445A1 Bicyclic compound
05/06/2010WO2010050168A1 Solid solution of valine, isoleucine and leucine, and method for producing same
05/06/2010WO2009144278A3 Conglutin-gamma as medicament and diet supplement
05/06/2010US20100113587 use of abscissic acid to treat various diseases, including neurodegenerative and neuromuscular diseases
05/06/2010US20100111977 Methods and compositions for treatment of myotonic dystrophy
05/06/2010CA2741793A1 Methods and means for efficient skipping of at least one of the following exons of the human duchenne muscular dystrophy gene: 43, 46, 50- 53
05/05/2010EP1115398B1 Tocopherols, tocotrienols, other chroman and side chain derivatives and uses thereof
05/05/2010CN1816353B Medicinal composition for preventing or treating Th1 type immunological disease
05/05/2010CN1630526B Systems and methods for treating patients with processed lipoaspirate cells
05/05/2010CN101701006A Phenethanolamine derivatives for treatment of respiratory diseases
05/05/2010CN101700385A Pharmaceutical composition medicinal liquor or tincture for curing white vein disease and preparation method thereof
05/04/2010USRE41315 Modulators of dopamine neurotransmission
05/04/2010US7709664 E.g., 3-arylmethyl-7-hydroxy-coumarins as intermediates; affects both the Tumor Necrosis Factor alpha level and transcription activity of NuclearFactor kappa Beta; antiimmunoinflammatory agents and autoimmune properties; antiarthritis agents; rheummatic diseases; osteoporosis; leukemia
05/04/2010US7709514 benzimidazole-2-one-5-n-pentanoate; inhibiting Macrophage Migration Inhibitory Factor (MIF); rheumatoid arthritis
05/04/2010US7709506 Kinase inhibitors to mediate disease and as antiinflammatory agents
05/04/2010US7709500 Chemical compounds
05/04/2010US7709486 antiviral compounds 1,4,8,11-tetraazacyclotetradecane derivatives for against HIV-infected cells, to inhibit the binding by the natural ligand to its chemokine receptor; viricides
05/04/2010US7709460 co-administration of a glutathione precursor (N-acetyl cysteine or alpha -lipoic acid) and hydroxocobalamin (a derivative of Vitamin B12) to patients with a functional Vitamin B12 deficiency and suffering from a neuropsychiatric abnormality
05/04/2010US7709452 Pharmaceutical composition which improves in vivo gene transfer
05/04/2010US7709228 Single-chain polypeptide fusion comprising functional binding, translocation and clostridial neurotoxin heavy chain domain for use as therapeutic agents and/or transporter molecules
05/04/2010US7709220 Methods of monitoring treatment of BAFF-R related disease
05/04/2010US7709020 Implantable device comprising phosphorus-containing macrolides
05/04/2010CA2462456C Androstane 17-beta-carboxamides as androgen receptor modulators
05/04/2010CA2350671C Riluzole and alpha-tocopherol combination
05/04/2010CA2312087C Preparation comprising sterically hindered amines for the prevention and treatment of inflammation
04/2010
04/29/2010WO2010020432A3 Compounds for treatment of duchenne muscular dystrophy
04/29/2010WO2010007316A3 Novel triazolo(4,3-a)pyridine derivatives, process for the preparation thereof, use thereof as medicaments, pharmaceutical compositions and novel use, in particular as met inhibitors
04/29/2010US20100105915 Chemokine receptor binding heterocyclic compounds
04/29/2010US20100105896 Pharmaceutical compounds
04/29/2010US20100105625 Product and Methods for Diagnosis and Therapy for Cardiac and Skeletal Muscle Disorders
04/29/2010US20100105603 Methods and Preparations For Curing Clinically Ill Patients
04/28/2010EP1472225B1 2-piperazine-pyridines useful for treating pain
04/28/2010CN1468307B Anti-dual integrin antibodies, compositions, methods and uses
04/28/2010CN101698096A Plaster for treating white vein diseases and preparation method thereof
04/28/2010CN101698095A Drug composition liniment or lotion for treating white vein diseases and preparation method thereof
04/28/2010CN101698094A Distillate for treating white vein diseases and preparation method thereof
04/28/2010CN101698093A Drug composition oral preparation used for relaxing tendons and activating collaterals and preparation method thereof
04/28/2010CN101698063A Plaster for treating facial paralysis and preparation method thereof
04/27/2010US7705125 Botulinum neurotoxin type E having increased biological half-life for use treatment and prevention of autonomic, neuromuscular and pain disorders
04/27/2010US7705124 Leucine-based motif and clostridial neurotoxins
04/27/2010US7705050 Amides, useful in the inhibition of IL-8-induced chemotaxis of neutrophils
04/27/2010US7705043 Methyl 4-{[(2-{4-[(4-bromophenoxy)methyl]-2,5-dimethyl-3-thienyl}ethyl)(5-ethoxy-5-oxopentyl)amino]methyl}benzoate, for example; treatment of cardiovascular and other diseases
04/27/2010US7704952 treating diabetes or obesity using isolated polypeptide is covalently modified with a water-soluble polymer
04/27/2010US7704526 Sustained release composition for oral administration of drugs
04/27/2010US7704524 Transdermal botulinum toxin administration for the treatment of spastic muscle pain
04/27/2010US7704498 Antiproliferative agents; anticancer agents; composition comprising antagonist of a human ErbB4 receptor, in admixture with a pharmaceutically acceptable carrier; antagonist selected from group consisting of an antibody produced by a hybridoma selected from the group containing HER4.10H1.1A1
04/27/2010CA2427482C Solid compositions suitable for oral administration containing non-hygroscopic salts of l-carnitine and the alkanoyl l-carnitines with taurine chloride and glycine chloride
04/22/2010WO2010044894A1 Methods and compositions for treatment of myotonic dystrophy
04/22/2010WO2010043010A1 N-acyl hydrazine derivatives, method for producing n-acyl hydrazine compounds, pharmaceutical compositions containing same, uses thereof and methods for treatment
04/22/2010WO2008047241A3 Modified corticotropin releasing factor peptides and uses thereof
04/22/2010US20100099723 Bioavailable compositions of metaxalone and processes for producing the same
04/22/2010US20100098736 Connective tissue repair
04/22/2010US20100098713 Drug screening; assay for aldehyde dehydrogenase activity; cancer
04/22/2010CA2777486A1 Methods and compositions for treatment of myotonic dystrophy
04/21/2010EP2177529A1 Novel -secretase inhibitor
04/21/2010EP2177520A1 1,5-Di(aryl or heteroaryl)-3-halo-2(1H)-pyridones as intermediates for the preparation of AMPA receptor inhibitors
04/21/2010EP2177513A1 Phenylacetic acid compound
04/21/2010EP2176230A2 Treatment of duchenne muscular dystrophy
04/21/2010EP1610780B1 Cyclic protein tyrosine kinase inhibitors
1 ... 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 ... 233